UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020595
Receipt number R000023775
Scientific Title Effect of education, and exercise program and on long term physical activity in post-operative breast cancer patients: randomised controll trial
Date of disclosure of the study information 2016/03/01
Last modified on 2020/07/20 17:17:16

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of education, and exercise program and on long term physical activity in post-operative breast cancer patients: randomised controll trial

Acronym

Effect of education, and exercise program in post-operative breast cancer patients

Scientific Title

Effect of education, and exercise program and on long term physical activity in post-operative breast cancer patients: randomised controll trial

Scientific Title:Acronym

Effect of education, and exercise program in post-operative breast cancer patients

Region

Japan


Condition

Condition

breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the effect of physical education program on long-term physical activity, quality of life, body mass index, bone densty, fatigue, cancer-related symtoms, lymph edema, and physcologial aspects in post-operative breast cancer patients.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase III


Assessment

Primary outcomes

physical activity at 1 year after registration

Key secondary outcomes

QOL, cancer- and treatment-related symptoms, fatigue, body mass index, bone density, lymph edema, anxiety and depression


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

3

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

education program

Interventions/Control_2

exercise program

Interventions/Control_3

control

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

1. Post-initial tretment (during 1 year after initial tretment) breast cancer patients with Stage 0-3.

2. Written informed consent.

Key exclusion criteria

Intolerance case with exercise program

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Naruto
Middle name
Last name Taira

Organization

Okayama university hospital

Division name

breast and endocrine surgery

Zip code

700-8558

Address

Shikata-cho 2-5-1, Okayama city

TEL

086-235-7265

Email

ntaira@md.okayama-u.ac.jp


Public contact

Name of contact person

1st name Naruto
Middle name
Last name Taira

Organization

Okayama university hospital

Division name

breast and endocrine surgery

Zip code

700-8558

Address

Shikata-cho 2-5-1, Okayama city

TEL

086-235-7265

Homepage URL


Email

ntaira@md.okayama-u.ac.jp


Sponsor or person

Institute

Okayama university

Institute

Department

Personal name



Funding Source

Organization

Kaken-B

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences and Okayama University Hospital, Ethics Committee

Address

Shikata-cho 2-5-1, Okayama city

Tel

086-235-6938

Email

mae6605@adm.okayama-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2016 Year 01 Month 26 Day

Date of IRB

2016 Year 01 Month 26 Day

Anticipated trial start date

2016 Year 03 Month 16 Day

Last follow-up date

2019 Year 03 Month 15 Day

Date of closure to data entry

2019 Year 07 Month 31 Day

Date trial data considered complete

2019 Year 08 Month 31 Day

Date analysis concluded

2019 Year 08 Month 31 Day


Other

Other related information



Management information

Registered date

2016 Year 01 Month 16 Day

Last modified on

2020 Year 07 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023775


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name